Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

J&J Fined for Illegal Price Controls in Suit with China Distributor

publication date: Aug 1, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Johnson & Johnson was ordered to pay a fine in China for monopolistic practices, in a suit stemming from a 2008 incident. Two of J&J’s subsidiaries were found guilty of enforcing price controls on a distributor. When the distributor won a public tender to sell J&J sutures – at a price below J&J’s stated minimum – J&J refused to supply product to the distributor. An appeals court awarded the distributor, Rainbow Medical, 530,000 RMB ($86,472). Rainbow had asked for a much larger 14 million RMB ($2.3 million). More details....

Stock Symbol: (NYSE: JNJ)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
More events coming soon...

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors